Pronounced how it sounds... Remdesivir. Gilead's antiviral drug was tested to treat Ebola patients — now it's the most promising potential COVID-19 treatment. A juicy report in STAT details its (apparent) effectiveness. More rigorous studies/trials/science are needed before we can celebrate a victory — but markets soared anyway as investors celebrated the chance this drug could work and help reopen the economy faster. How it went down read like a screenplay:
Opening up America (Again?)... Not sure what the again is about, but there might be one if the economy reopens too soon. Last week, the White House recommended a 3-phase plan for states to reopen (when safe). Approval for a COVID-19 treatment could speed up this reopening, but it's not the only consideration...
There are 3 parts to this medical solution... All 3 will be necessary to (completely) end the corona-crisis: